Literature DB >> 31092117

Predicting short- and long-term cognitive training success in healthy older adults: who benefits?

Mandy Roheger1, Julia Meyer2, Josef Kessler3, Elke Kalbe1.   

Abstract

Identifying factors predicting effects of cognitive trainings (CT) is important for developing trainings for individuals with specific profiles. The objective of the present study was to evaluate predictors of CT success in several cognitive domains directly after and 1 year after a 7-week group CT in healthy older adults. Sociodemographic variables, baseline cognitive performance, physical activity parameters, apolipoprotein E-4 (apoE-4), levels of insulin-like growth factor 1 (IGF-1), brain-derived neurotrophic factor (BDNF), and vascular endothelial growth factor (VEGF) were analysed as possible predictors of CT success. Outcomes were assessed directly after training  and 1 year after CT. Results indicate that lower initial baseline performance was a significant predictor for CT success in most of the investigated domains. All tested predictors (except age and BDNF) predicted CT success in different domains. Our data indicate that healthy older adults with lower cognitive baseline scores show stronger benefits of a CT group intervention.

Entities:  

Keywords:  Prediction; cognition; healthy older adults; training benefits

Mesh:

Substances:

Year:  2019        PMID: 31092117     DOI: 10.1080/13825585.2019.1617396

Source DB:  PubMed          Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn        ISSN: 1382-5585


  8 in total

1.  A Systematic Review on Predictors of Working Memory Training Responsiveness in Healthy Older Adults: Methodological Challenges and Future Directions.

Authors:  Anja Ophey; Mandy Roheger; Ann-Kristin Folkerts; Nicole Skoetz; Elke Kalbe
Journal:  Front Aging Neurosci       Date:  2020-10-14       Impact factor: 5.750

Review 2.  Prognostic factors for change in memory test performance after memory training in healthy older adults: a systematic review and outline of statistical challenges.

Authors:  Mandy Roheger; Ann-Kristin Folkerts; Fabian Krohm; Nicole Skoetz; Elke Kalbe
Journal:  Diagn Progn Res       Date:  2020-05-21

Review 3.  From Evaluation to Prediction: Behavioral Effects and Biological Markers of Cognitive Control Intervention.

Authors:  Bin Xuan
Journal:  Neural Plast       Date:  2020-02-24       Impact factor: 3.599

4.  Nothing wrong about change: the adequate choice of the dependent variable and design in prediction of cognitive training success.

Authors:  André Mattes; Mandy Roheger
Journal:  BMC Med Res Methodol       Date:  2020-12-07       Impact factor: 4.615

5.  Prognostic Factors and Models for Changes in Cognitive Performance After Multi-Domain Cognitive Training in Healthy Older Adults: A Systematic Review.

Authors:  Mandy Roheger; Hannah Liebermann-Jordanidis; Fabian Krohm; Anne Adams; Elke Kalbe
Journal:  Front Hum Neurosci       Date:  2021-04-27       Impact factor: 3.169

6.  Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial.

Authors:  Elke Kalbe; Karsten Witt; Nele Schmidt; Inken Tödt; Daniela Berg; Christian Schlenstedt; Ann-Kristin Folkerts; Anja Ophey; Karina Dimenshteyn; Saskia Elben; Lars Wojtecki; Inga Liepelt-Scarfone; Claudia Schulte; Patricia Sulzer; Carsten Eggers
Journal:  J Neurol       Date:  2021-04-27       Impact factor: 6.682

7.  Can a serious game-based cognitive training attenuate cognitive decline related to Alzheimer's disease? Protocol for a randomized controlled trial.

Authors:  Esther Brill; Christine Krebs; Michael Falkner; Jessica Peter; Katharina Henke; Marc Züst; Lora Minkova; Anna-Katharine Brem; Stefan Klöppel
Journal:  BMC Psychiatry       Date:  2022-08-12       Impact factor: 4.144

8.  Predictors of changes after reasoning training in healthy adults.

Authors:  Mandy Roheger; Elke Kalbe; Anne Corbett; Helen Brooker; Clive Ballard
Journal:  Brain Behav       Date:  2020-09-27       Impact factor: 2.708

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.